Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02342873Not ApplicableCompleted

Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery

Role: lead

NCT02808546Completed

The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute

Role: lead

NCT02344615Not ApplicableCompleted

Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block

Role: lead

NCT02027311Phase 4Completed

Etomidate vs. Midazolam for Sedation During ERCP

Role: lead

NCT02307773Completed

Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy

Role: lead

NCT02326948Completed

Alcohol Consumption and Gallbladder Cancer

Role: lead

NCT02014766Not ApplicableUnknown

Supraclavicular Versus Interscalene Block

Role: lead

NCT01903902Phase 4Unknown

Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries

Role: collaborator

NCT01894321Completed

The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy.

Role: lead

All 9 trials loaded